WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , 

ISSN 2457-0400

Impact Factor  :  6.711

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased to 6.711 for Year 2024.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR March 2023 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

  • WJAHR: MARCH ISSUE PUBLISHED

    March 2024 Issue has been successfully launched on 1 March 2024.

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

PRESCRIPTION PATTERN OF GOUT: A PROSPECTIVE STUDY

Mukesh Kumar Chaudhary*, Kajol Chaudhary, Krishna Chaudhary Tharu, Niruta Jamarkattel, Sita Nepali and Sundar Neupane

ABSTRACT

Gout is a common metabolic disorder which occurs due to excessive deposition of uric acid in different bone joints. The incidence of gout has also risen rapidly in Nepal in the past decades. Men are three times more likely than women to develop gout. It tends to affect men after age 40 and women after menopause. The aim was to study the prescription pattern of gout drugs in gouty outpatients in Crimson Hospital, Manigram, Rupandehi. Hospitalized and patient below 20 years of age were excluded from the study. A total of 110 cases were included in the study. The result of this study shows that most of the gout patients were male in comparison to female and fell under the age group from 40-49 years (37.27%) followed by 50–59 year age group (25.45%). It was found that alcohol consumers patient was more in number than smokers and tobacco consumers. Brahmin patients (43.64%) were mostly diagnosed with gout in comparison to other races. In occupation wise distribution most of the gout patients were business (25.45%) followed by service (19.09%). In our study, hypertension (28.18%) shows the highest diagnosis of diseases in patient with gout. Combination therapy is more common than mono-therapy. Combination of three drugs is most frequently used among the patients. Most of the prescribed gout drugs were Febuxostat along with NSAIDs and Proton Pump Inhibitors (Pantoprazole) followed by Colchicine with NSAIDs and Pantoprazole. Oral route was mostly preferred rather than intravenous routes.

[Full Text Article] [Download Certificate]